This course has expired. You can still review the content but course credit is no longer available.
Managing patients with retinal diseases is never simple, but with the COVID-19 pandemic, this challenge has become even more difficult as ophthalmologists are struggling to provide the best treatment while limiting office visits. Longer duration therapies are helping to meet those needs.
This webinar will focus on the latest data in diabetic macular edema treatment, comparing clinical trial versus real-world strategies, and the panel will discuss ways to adapt patient care in the COVID-19 era.
This certified CME activity is designed for retina specialists and general ophthalmologists involved in the management of patients with diabetic macular edema.
Supported through an unrestricted educational grant by Alimera Sciences.
Upon completion of this activity, the learner should be able to:
Provided by Evolve Medical Education
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this live material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Recommended internet speed 5Mbps+
Christina Y. Weng, MD, MBA
Baylor College of Medicine
Sophie J. Bakri, MD
Professor of Ophthalmology
Maria H. Berrocal, MD
Berrocal & Associates
San Juan, Puerto Rico
Sumit Sharma, MD
Assistant Professor, Ophthalmology
Cleveland Clinic Lerner College
Case Western Reserve University Staff in Vitreoretinal Surgery
Cleveland Clinic Cole Eye
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Christina Weng, MD, MBA and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Alcon, Alimera Sciences, Allergan, and Novartis.
Sophie J. Bakri, MD, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Adverum, Allegro, Allergan, Alimera Sciences, Eyepoint, Kala, Oxurion, Novartis, and Roche. Grant/Research Support: Lowey Medical Foundation and NIH.
Maria H. Berrocal, MD, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Alcon, Alimera Sciences, and Allergan. Speaker’s Bureau: Alcon, Alimera, Allergan and Quantel.
Sumit Sharma, MD, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Alimera Sciences, Allergan, Bausch + Lomb, Clearside, EyePoint, Genentech/Roche, and Regeneron.
The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Alimera Sciences.